Latest Headlines

Reporting and Analysis by David Wong.

DAVID WONG 2026-08-11

Akeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancer

Akeso, a leading biopharmaceutical company, has initiated a Phase II clinical study for its innovative TROP2/Nectin-4 bispecific ADC, AK146D1, in combination with Ivonescimab for breast cancer treatment. This marks a significant step in advancing their IO2.0 and ADC2.0 strategies, aimed at improving patient outcomes in oncology.

DAVID WONG 2026-08-11

Moore Threads Eyes Hong Kong Listing After Impressive Revenue Surge

Chinese GPU manufacturer Moore Threads is set to pursue a public listing in Hong Kong following a remarkable 147% increase in revenue during the first half of the year. This move highlights the growing significance of the semiconductor industry in the region and the company's ambitions in the global market.

DAVID WONG 2026-08-11

Hong Kong: The Ultimate Cosplay Halloween Experience

This Halloween, Hong Kong transforms into a vibrant hub for cosplay enthusiasts, showcasing creativity and community spirit. From themed parties to elaborate costumes, the city offers a unique blend of culture and entertainment for all ages.